To evaluate the role of oncogenic RAS mutations in pancreatic tumorigenesis, we directed endogenous expression of KRAS G12D to progenitor cells of the mouse pancreas. We find that physiological levels of Kras G12D induce ductal lesions that recapitulate the full spectrum of human pancreatic intraepithelial neoplasias (PanINs), putative precursors to invasive pancreatic cancer. The PanINs are highly proliferative, show evidence of histological progression, and activate signaling pathways normally quiescent in ductal epithelium, suggesting potential therapeutic and chemopreventive targets for the cognate human condition. At low frequency, these lesions also progress spontaneously to invasive and metastatic adenocarcinomas, establishing PanINs as definitive precursors to the invasive disease. Finally, mice with PanINs have an identifiable serum proteomic signature, suggesting a means of detecting the preinvasive state in patients.
Introduction
del Castillo, 1992) . The essential incurability of this disease is reflected in virtually identical annual incidence and mortality Infiltrating ductal adenocarcinoma of the pancreas (PDA) acfigures, projected to number 30,300 and 29,700 cases, respeccounts for over 95% of all exocrine pancreatic malignancies tively, for (Jemal et al., 2003 . The median survival for and is the fifth-leading cause of cancer-related deaths in the patients with PDA is 4-6 months, in part because the disease United States. Infiltrating PDA is almost uniformly fatal, with a usually only becomes clinically apparent at late stages, and because it resists all forms of conventional chemotherapy and five-year survival of less than 5% (Warshaw and Fernandez- radiotherapy. Several factors conspire to obscure the diagnosis to complete surgical resection, long-term survival is exceedingly rare. The vast majority of even highly selected patients, posof early pancreatic ductal cancer, including the retroperitoneal location of the pancreas and the small size of most of the sessing small primary lesions (less than 2 cm), disease-free resection margins, and negative lymph nodes, inevitably sucprecursor lesions, which renders them below the detection threshold of current imaging modalities. Even when serendipicumb to recurrent or metastatic disease (Allison et al., 1998; Yeo et al., 2002a) . Thus, unlike other epithelial malignancies, it tously discovered at its earliest stages, and therefore amenable appears that from its very inception, PDA is already a micro- (Kawaguchi et al., 2002) and into endocrine cells that migrate to the spleen (Krapp et al., 1998) . P48 Ϫ/Ϫ animals lack a discernible metastatic disease. Understanding the pathogenesis of the preinvasive state, and developing effective strategies to detect pancreas and succumb shortly after birth. The PDX-1 and P48 double-positive progenitor cells give rise to all the mature cells preinvasive pancreatic neoplasms, are therefore of paramount importance.
of the pancreas ( Figure 1A ). In the adult mouse, PDX-1 expression is essentially confined to the islet cells, while P48 is reSimilar to long-established models for other epithelial malignancies, such as breast, colon, and prostate, a progression stricted to acinar cells. To target expression of oncogenic KRAS to pancreatic promodel for the precursor lesions of PDA has been elaborated Fitzgerald, 1975, 1976; Hruban et al., 2000a; Klims- genitor cells, a conditionally expressed allele was first constructed as previously described (Jackson et al., 2001 ) (Figure tra and Longnecker, 1994) . These lesions, recently codified under the collective term pancreatic intraepithelial neoplasia 1B). The targeting vector contains genetic elements that inhibit transcription and translation flanked by functional LoxP sites. (PanIN), are grouped into three histologic stages based on increasing degrees of architectural and nuclear atypia (Kern et This Lox-STOP-Lox (LSL) construct was inserted into the mouse genomic KRAS locus upstream of a modified exon 1 engineered al., 2001) . A genetic progression model is also emerging which serves to substantiate and illuminate the histological description to contain a G → A transition in codon 12. This mutation, commonly found in human PDA, results in a glycine to aspartic acid (Hruban et al., 2000b) . Activating mutations in the KRAS protooncogene are found in over 90% of invasive PDA and are substitution in the expressed protein, compromising both its intrinsic and extrinsic GTPase activities and resulting in constituthought to represent an initiating event. Genetic and epigenetic inactivations of a number of tumor suppressor genes, including tive downstream signaling of Ras effector pathways. Expression of the mutated allele is achieved by interbreeding LSL-KRAS G12D p16
INK4a
, p53, DPC4 and BRCA2, increase in frequency in progressively higher PanIN stages, and culminate in incidences of mice with animals that express Cre recombinase from the pancreatic-specific promoters, PDX-1 or P48. Lineage tracing studapproximately 90%, 50%-70%, 55%, and 10%, respectively, in invasive PDA. A few heritable predispositions to the disease ies demonstrate a stochastic pattern of Cre expression in the pancreas of the transgenically derived PDX-1-Cre animals, while have been described, involving kindreds with germline mutations in the tumor suppressor genes p16
, BRCA2, LKB1, the knockin strategy used to generate the P48 ϩ/Cre strain (Kawaguchi et al., 2002) results in uniform expression throughout the and MLH1 (Jaffee et al., 2002) . Interestingly, the median age at presentation in these kindreds is not significantly different from organ (Supplemental Figure S1 at http://www.cancercell.org/ cgi/content/full/4/6/437/DC1). Prior to breeding with Cresporadic cases, suggesting that these mutations identify genes involved in the progression, and not initiation, of a multigenic expressing animals, LSL-KRAS G12D mice are functionally heterozygous for the wild-type allele (KRAS ϩ/Ϫ ). Excision of the siprocess.
A number of tumor suppressor gene knockout and oncolencing cassette and subsequent recombination allows for expression of the mutant allele, resulting in a heterozygous gene transgenic mouse models have been developed in recent years incorporating strategies informed by the genetic studies mutant condition (KRAS ϩ/G12D ). The excision-recombination event leaves behind a single LoxP site, evidence of which can cited above; to date, however, none have recapitulated the features of invasive human PDA or of its noninvasive precursor be demonstrated by PCR ( Figure 1C ). Note that only DNA isolated from the pancreata of these mice, and not from the tails, state. We hypothesized that physiological levels of oncogenic KRAS would serve to initiate pancreatic cancer. We report here reveals evidence of recombination. The pancreata from compound mutant mice are larger than that endogenous expression of KRAS G12D in progenitor cells of the mouse pancreas induces the entire progression of pancretheir littermate controls and, particularly in older mice, often have focally nodular parenchyma ( Figure 1D ). Consistent with atic ductal adenocarcinoma from preinvasive neoplasias to invasive and metastatic disease. Furthermore, mice with preinvasive expression of the KRAS G12D allele, total protein lysates from the pancreata of compound mutant mice contain mutant protein disease have a diagnostic serum proteomic profile that could serve as the basis for detecting the cognate human condition.
and reveal increased levels of activated, or GTP-bound, Ras ( Figure 1E ). The slightly higher levels of Kras G12D and Ras-GTP in P48 ϩ/Cre ;LSL-KRAS G12D pancreatic lysates are consistent with Results expression of the mutant allele throughout the organ. These studies do not, of course, identify the specific cellular compartTargeting expression of KRAS
G12D
to the mouse pancreas ment(s) within the pancreas that express the KRAS G12D allele. Nevertheless, they do establish that the conditional KRAS
The ability to target gene expression to different compartments of the mouse pancreas has been aided greatly by recent adallele is efficiently recombined in the pancreata of PDX-1-vances in our understanding of the developmental program of Cre;LSL-KRAS G12D and P48 ϩ/Cre ;LSL-KRAS G12D compound muthis vital organ. These studies have identified several transcriptant mice, resulting in expression of the oncogenic protein and tion factors critical to cellular fate decisions in the developing elevated Ras-GTP levels. pancreas (reviewed in Kim and MacDonald, 2002) (Figure 1A ). The first identifiable pancreatic progenitor cells arise in the dorEndogenous KRAS G12D expression induces pancreatic intraepithelial neoplasias (PanINs) sal and ventral endoderm at embryonic day 8 in the fetal mouse. Expression of PDX-1/IPF1 occurs around E8.5, and its homozyThe pancreata of compound mutant mice developed ductal lesions with complete penetrance (33 of 33 animals) that were gous deletion is an embryonic lethal event (Offield et al., 1996) . P48/PTF1 is expressed slightly later and is required to commit identical to all three stages of human PanINs. Representative examples of the types of lesions seen in these animals are cells to a pancreatic fate; when it is absent, cells of the developing pancreatic bud instead differentiate into duodenal epithelium shown (Figure 2 ). The normal pancreas is characterized by an A: Wild-type pancreas revealing normal cuboidal ductal epithelium in cross-section (arrowhead), islet (is), and surrounding acinar tissue (400ϫ). B: Reactive duct (arrow) showing enlarged nuclei and normal duct (arrowhead) in adjacent lobule (400ϫ). C: PanIN-1A in small intralobular duct (arrow) and adjacent normal interlobular duct (delimited by arrowheads). Note the relative sizes of the two ductal structures (200ϫ). D: PanIN-1A (arrow) and adjacent normal duct (arrowhead) and islet (is) (400ϫ). E: showing papillary architecture and an adjacent PanIN-1A (arrowhead) (400ϫ). F: Papillary architecture of PanIN-1B lesion at abrupt transition from more normal appearing ductal epithelium (arrowheads) (1000ϫ). G and H: Higher-grade PanIN-2 lesions (arrows) reveal more significant loss of polarity and moderate nuclear atypia. In (G), an adjacent lesion within the same duct has features more consistent with PanIN-1B (arrowhead, 400ϫ). I-L: High-grade PanIN-3 lesions reveal complete loss of cellular polarity, significant nuclear atypia, and budding of cell clusters into the ductal lumen. Goblet cells (arrows) are also seen with increasing frequency, as is the surrounding fibroinflammatory reaction (asterisk) (1000ϫ).
abundance of acinar tissue with scattered islets and rarely-seen ( Figure 2B ). PanIN-1A lesions are characterized by a transition from the normal cuboidal morphology to a columnar phenotype ducts ( Figure 2A ). Normal ductal epithelium is comprised of cuboidal cells with uniform round nuclei. Occasionally, so-called with abundant supranuclear, mucin-containing cytoplasm (Figures 2C and 2D) . The polarity of these cells is still maintained reactive ducts, which are thought to reflect injured epithelium, are seen. These ducts are characterized by slightly larger nuclei with basally located nuclei, and nuclear atypia, when seen at all, is minimal. Such lesions were observed in compound mutant with less condensed chromatin, but only minimally increased cytoplasm, and are not thought to represent preinvasive lesions mice as young as two weeks old. We note that the development of these lesions was restricted to the small, intralobular ducts specification of this region of the developing foregut endoderm (Kawaguchi et al., 2002) . The relative infrequency of such events of the pancreas, just as in the human condition; the larger interlobular ducts appeared unaffected ( Figure 2C ). The developis also reflected in the lack of detectable recombination of the LSL-KRAS G12D allele in the duodena of most P48 ϩ/Cre ;LSL G12D ment of papillary or micropapillary ductal lesions without significant loss of polarity or nuclear atypia identifies them as animals (Supplemental Figure S2F ). PanIN-1B ( Figures 2E and 2F) . Importantly, the pancreata of affected animals retained their overall organotypic architecture
Characterization of PanINs
The proliferative index of PanINs was assessed by expression with abundant normal-appearing acini and islets.
As the mice aged, higher-grade PanINs were observed with of PCNA. In wild-type animals, the basal level of PCNA expression was low, measuring 0.55 Ϯ 0.05% in ducts, 0.94 Ϯ 0.14% increasing frequency. Moderate nuclear atypia and a loss of polarity, manifested by movement away from a strictly basal in acini, and 0% in islets. ;LSL-KRAS G12D animals, 16% Ϯ 1.8% and location of nuclei, herald the transition to PanIN-2 lesions (Figures 2G and 2H) . In PanIN-3 lesions, significant nuclear atypia 22% Ϯ 3.0%, respectively, of ductal cells in PanINs expressed PCNA ( Figure 3A) . The proliferative index of acinar cells in comand complete loss of polarity are observed, such that it is often not possible within the center of one of these lesions to discern pound mutant animals was also increased, though to a much lesser degree than PanINs: 3.0 Ϯ 0.6% of acinar cells in PDX-1-luminal from basal boundaries ( Figures 2I-2L ). Goblet cells, mucus-producing cells normally restricted to respiratory and intesCre;LSL-KRAS G12D mice were PCNA-positive, while 6.7 Ϯ 0.8% PCNA-positive acinar cells were observed in P48 ϩ/Cre ;LSLtinal epithelia, were seen in PanINs of various stages, but most frequently in PanIN-3 lesions. Though not part of the formal KRAS G12D animals. Neither the normal ductal cells nor islet cells in either cohort of compound mutant animals showed any indiagnostic criteria for PanINs, they are an associated hallmark of human PanINs and are consistent with the notion of an undifcrease in PCNA expression ( Figure 3B ). Importantly, pancreata from compound mutant animals did not express detectable ferentiated or inappropriately differentiated pancreatic ductal epithelium toward a more intestinal phenotype. In the PanIN-3 levels of p21
, a cell cycle inhibitor and p53 target gene ( Figure 3C ), arguing against the possibility that the decreased lesions shown here, nuclear enlargement and pleomorphism are apparent; in addition, clusters of cells can be seen which proliferative rates of acinar and islet cells compared with PanINs were due to Ras-induced senescence in the former cell comappear to have "budded off" into the lumen. These represent cardinal features of human PanIN-3 lesions, also referred to as partments (Serrano et al., 1997) . The epithelial nature of the observed PanINs was confirmed carcinoma-in-situ.
In many of the older mice, the pancreata contained extensive by intense expression of cytokeratin-19 (CK-19), an epithelial cell marker (Figures 3D). Consistent with human PanINs, and ductal lesions, and the acinar parenchyma was largely replaced by an intense stromal, or desmoplastic, reaction comprised of with their presumptive status as precursors of adenocarcinomas, an abundant mucin content of PanINs in compound mutant inflammatory cells, fibroblasts, and collagen deposition ( Figures  2I-2K ). This fibroinflammatory reaction is highly reminiscent of animals was demonstrated by intense Alcian blue staining (Figure 3E) and by immunoreactivity to the mucin-specific protein, that seen in human pancreatic cancers and may be secondary to luminal obstruction from the intraductal proliferations. A similar Muc5 ( Figure 3F ). Finally, we note that PanINs expressed only low levels of PDX-1, which can nevertheless be discerned when spectrum of ductal lesions was seen with both PDX-1-Cre;LSL-KRAS G12D and P48
ϩ/Cre
;LSL-KRAS G12D mice. We conclude, therecompared to the lack of expression in surrounding acini (Figures 2G and 2H) and to normal ducts in control animals ( Figure  fore , that the targeted recombination of a conditional KRAS G12D allele in pancreatic progenitor cells induces the full spectrum 2I). Moderate expression of PDX-1 was observed in duodenal crypts, again consistent with the observation of allelic recombiof pancreatic intraepithelial neoplasias, and substantiates the KRAS G12D mutation as an initiating event in pancreatic cancer. nation in the small bowel noted earlier, while high levels of PDX-1 expression were restricted to the endocrine cells of both PDX-1-Cre;LSL-KRAS G12D animals did occasionally develop additional tumors with varying penetrance (Supplemental Table  control and compound mutant adult animals, as expected . S1), including mucocutaneous papillomas (not shown), intestinal metaplasia of the gastric epithelium (Supplemental Figures S2A and S2B) , and hyperplastic polyps of the duodenum (SupplePanINs show evidence of histologic progression To determine more rigorously if the PanINs progress histologimental Figures S2C and S2D ). The occurrence of these lesions of the gastrointestinal epithelium likely reflects the expression cally, the total number of ductal lesions and their grade were scored in representative pancreatic sections of cohorts of PDXof PDX-1 in foregut endothelium progenitor cells during development (Offield et al., 1996) . Consistent with this expression pat-1-Cre;LSL-KRAS G12D mice of varying age ( Figure 4 ). To decrease the likelihood of scoring the same potentially serpentine duct tern, recombination of the conditional allele was detected in the stomach and small bowel, in addition to the pancreas, of PDXmore than once, only the highest-grade lesion per pancreatic lobule was evaluated. Reactive ducts were not counted as true 1-Cre;LSL-KRAS G12D mice, as well as in cutaneous papillomas but not normal adjacent skin (Supplemental Figure S2E) . With PanINs. Only lesions that satisfied the accepted criteria for PanIN grades 1-3 were scored as such. It should be noted that one exception, full necropsies of P48 ϩ/Cre ;LSL-KRAS G12D animals did not reveal extrapancreatic pathology (Supplemental Table  a fair degree of variability exists in total tumor burden among mice of the same age, even among littermates. This variability S2). One animal displayed evidence of duodenal hyperplasia (not shown), perhaps a result of haploinsufficiency of P48 in may reflect the inherently unpredictable nature of transgenic expression of the Cre enzyme in PDX-1-Cre mice. This caveat P48 ϩ/Cre mice. In lineage-tracing studies in P48 ϩ/lacZ mice, rare P48-expressing cells were retained in the duodenum, the prenotwithstanding, several points were readily apparent. Both the total number of PanINs and their grade clearly increased with sumed result of insufficient levels of p48 to secure the pancreatic E: Alcian blue stain reveals abundant mucin content of a PanIN-1A (arrow) which is absent from islets (is), acini (ac), and an adjacent reactive duct (arrowhead) (400ϫ). F: Immunoreactivity to mucin-specific protein, Muc5, is seen in PanINs (arrows), but not in adjacent acini (ac) (400ϫ). G-I: Immunohistochemical detection of PDX-1 expression in pancreata from PDX-1-Cre; LSL-KRAS G12D (G and H) and control mice (I). G: Intense nuclear PDX-1 expression is seen in islets (arrowhead), high-level expression in intestinal crypts (open arrowheads), and faint expression in 200ϫ) . H: Higher-power view of G (400ϫ). I: High-level expression in islets (is) but not in ducts (arrowhead) (400ϫ).
advancing age of the mice (Figure 4) . In animals 5 months of age PanINs activate normally quiescent pathways We next sought to examine these lesions with specific regard or less, the vast majority of ducts were normal. When observed, to pathways that offer potential therapeutic and/or chemoprevductal lesions were largely PanIN-1A. Specifically, at 2.25 entive targets. The Notch signaling pathway is involved in demonths, Ͼ80% of ducts were normal; this percentage determining cellular fate in the embryonic development of a variety creased to 68% at 4-5 months (p Ͻ .089, using Poisson regresof tissues (Artavanis-Tsakonas et al., 1999) , as well as in the sion). By 7-10 months, however, more neoplastic (82% of total) pathological state associated with Alzheimer's disease (Fortini, than normal ducts were observed (p Ͻ 1 ϫ 10 Ϫ8 compared with 2002). Although apparently necessary for the early development 2 months, p Ͻ 1.5 ϫ 10 Ϫ4 compared with 4.5 months). Although of the pancreas, Notch signaling is normally suppressed in the the neoplastic ducts still largely consisted of low-grade (1A and adult organ (Apelqvist et al., 1999; Jensen et al., 2000) . Very 1B) lesions (65%), a substantial number of grade 2 lesions (16%) recently, this pathway has been identified as inappropriately and the first PanIN-3 lesions could now be seen. Relative to upregulated in human pancreatic cancer specimens (Miyamoto the total number of ducts, the incidence of high-grade (2 and et al., 2003) . Activation of this pathway can be assessed by 3) PanINs in the oldest cohort was significantly increased when nuclear expression of one of its downstream target genes, the compared with both young (p Ͻ 7 ϫ 10 Ϫ5 ) and intermediatetranscription factor Hes1. PanIN lesions demonstrated strong aged mice (p Ͻ 4 ϫ 10 Ϫ4 ), largely because high-grade lesions nuclear expression and faint cytoplasmic expression of Hes1 were rarely if ever observed in mice younger than 5 months.
( Figure 5A ). Nuclear expression was not seen in the normal Similar overall findings were noted in cohorts of P48 ϩ/Cre ;LSLducts or islet cells of compound mutant animals, or in these compartments in control animals ( Figure 5B ); expression in rare KRAS G12D mice.
nohistochemical labeling for Cox-2 was observed in the cytoplasm of PanINs, but not in the ductal cells of control animals ( Figures 5C and 5D ). Acini and islets revealed varying, but substantially decreased, levels of COX2 expression. Finally, we investigated the expression of matrix metalloproteinase-7 (MMP-7), a member of the family of zinc-dependent extracellular proteases (Brinckerhoff and Matrisian, 2002) . Homozygous deletion of MMP-7 has been shown to inhibit tumorigenesis (Wilson et al., 1997) , while transgenic overexpression can promote it (Rudolph-Owen et al., 1998) . Inappropriate MMP-7 expression has also been identified in preinvasive and invasive human pancreatic cancer specimens (Crawford et al., 2002) . We found focally elevated expression of MMP-7 in a subset of PanIN lesions, but not in the normal ducts or other cells of the pancreas (Figures 5E and 5F ), similar to the pattern of expression seen in human specimens. Interestingly, and again as noted in human pancreata, MMP-7 expression did not appear to correlate with PanIN grade. In a cohort of animals (n ϭ 29) being followed longitudinally 2, 3) in mice of average age 2.25 months (n ϭ 6), 4.5 months (n ϭ 4), and
Progression to invasive and metastatic
for evidence of disease progression, two mice, one PDX-1-9 months (n ϭ 4). p values: *, Ͻ 1 ϫ 10 Ϫ8 ; **, Ͻ 1.5 ϫ 10 Ϫ4 ; ⌬, Ͻ 7 ϫ 10 Ϫ5 ;
Cre;LSL-KRAS G12D (aged 6.25 months) and one P48 developed additional sites of metastatic disease and will be been described previously (Miyamoto et al., 2003) .
described in greater detail. PanINs also expressed increased levels of cyclooxygenase At necropsy, a profuse hemorrhagic ascites was noted. The 2, a component of the prostaglandin pathway involved in the pancreas was large, firm, and fibrotic, and appeared to be eninflammatory response. Elevated COX2 expression has been casing the small bowel ( Figure 6A ). Nodular densities were obdescribed in both human PanINs (Maitra et al., 2002) and invasive PDA (Maitra et al., 2002; Tucker et al., 1999) . Intense immuserved on the liver, diaphragm, and pleural surfaces. Histologic assessment of the pancreas revealed a diffusely infiltrative ade-( Figure 6H ). These more well-differentiated regions of the tumor also reacted with Alcian blue and with mucicarmine, a mucinnocarcinoma with scattered low and high grade PanINs ( Figures  6B-6D) . A predominantly glandular pattern of differentiation was specific stain, establishing their designation as a glandular mucin-producing carcinoma, or adenocarcinoma (not shown). noted ( Figures 6E and 6F) , although there were significant areas of more poorly differentiated carcinoma as well ( Figure 6G ).
The liver contained numerous scattered metastatic lesions which clearly revealed glandular differentiation (Figures 6I and The regions manifesting glandular differentiation, in particular, expressed high levels of CK-19, confirming their epithelial nature 6J) and which also were CK-19-positive ( Figure 6K ). A similar histologic appearance and epithelial character was demonconfirmed PanIN, but no evidence of invasive or metastatic disease. Twenty-five age-matched littermate controls (a mix of strated by metastases to the lung parenchyma ( Figure 6L ) and pleural surfaces (Figures 6M and 6N ). Several identified peripanwild-type, PDX-1-Cre, and P48 ϩ/Cre mice) were similarly bled and sacrificed, and were confirmed to have normal pancreata creatic lymph nodes had been infiltrated by tumor cells ( Figure  6O ), and finger-like projections of tumor cells had invaded into without histologic evidence of PanIN. A total of 25 PanIN serum samples and 40 samples from littermate controls were subthe diaphragm ( Figure 6P) . A metastatic lesion to the adrenal cortex was also noted (not shown).
jected to SELDI-TOF mass spectrometry to generate an unblinded training set for our bioinformatics algorithm. The resulThe presence of neural and vascular invasion in human pancreatic ductal cancer portends an especially poor prognosis, tant model was highly predictive, with a sensitivity of 90.5% (95% CI of 68.3-98.8%) and a specificity of 97.7% (95% CI of and invasion of nervous plexi is a major source of patient morbidity, resulting in severe and often intractable pain. Invasion 87.7%-99.9%). These results suggested, in principle, that the serum proteome of compound mutant mice with preinvasive of a nervous plexus and encasement of the nerve fibers by tumor cells was observed in this animal as well ( Figure 6Q ). pancreatic ductal disease is distinguishable from that of healthy littermate controls. Cancer cells can be seen completely encasing the nerve fibers and infiltrating the plexus of neuronal cell bodies. Not surprisHaving established the potential feasibility of detecting preinvasive pancreatic disease in this small study, we next endeavingly, vascular invasion manifested by infiltration of a vein was also noted (not shown). The sites of metastases observed in ored to perform a prospective study on a larger set of serially collected samples and subject them to higher resolution mass this animal are precisely those found in human pancreatic ductal adenocarcinoma and further underscore the accuracy of this spectrometry. For these analyses, we used a younger cohort of animals of average age 5.5 Ϯ 0.25 months. The use of younger mouse model in recapitulating the path to the human disease.
mice increases the stringency of the test in several ways. First, these animals have a lower total burden of PanINs and a shift Identification of a proteomic signature in mice with PanIN toward earlier stage lesions (see Figure 4) . Compound mutant mice at this age have a vast majority of normal (67%) as comSerum proteomic analysis has recently been shown to be an effective means to detect early or recurrent malignancy in papared with diseased ducts (33%). Second, and as a direct consequence, such animals are much less likely to have developed tients with ovarian (Petricoin et al., 2002b) , breast (Li et al., 2002) , and prostate cancer (Adam et al., 2002; invasive ductal cancer. Third, and perhaps most importantly, they have substantially less chronic injury and fibrosis than the 2002a). These studies coupled a high-throughput mass spectrometric method, surfaced enhanced laser desorption ionization older cohort. It is formally possible that the signature identified in the initial pilot study represented the presence of pancreatic time-of-flight (SELDI-TOF), with pattern recognition algorithms to detect significant differences that exist between patients and fibrosis and not PanIN. Thus, we used this cohort of animals to determine if it was possible to detect very early preinvasive healthy subjects in the low molecular weight range (less than 20,000 MW) of the serum proteome. We wondered whether the disease and to do so in the relative absence of the underlying fibrosis that accompanies the greater PanIN burden found in serum from PanIN-afflicted animals contained an identifiable proteomic profile that distinguished diseased from normal aniolder animals. Independent, serial serum collections were performed on a mals. We note that unfractionated serum was used for these analyses, as it has recently been shown that retention of albumin cohort of 39 compound mutant animals of average age 5.5 Ϯ 0.25 months and 40 aged-matched littermate controls to generis essential to the diagnostic power of sera from ovarian and prostate cancer patients, presumably because albumin avidly ate a total of 80 PanIN and 111 control serum samples. All animals were followed for a minimum of three additional weeks binds the low MW proteins and concentrates them over time by preventing their otherwise inevitable renal excretion (Liotta after the final serum collection without manifesting overt signs of illness, further decreasing the likelihood that they had developed et al., 2003) .
In a small pilot study designed to establish proof-of-princiinvasive disease. Training on a subset of 46 PanIN samples and 51 control samples generated a model comprised of 10 specific ple, we used a cohort of mice of average age 9.0 Ϯ 0.2 months, which would be expected to have a very high burden of PanINs: molecular ions whose vectorially combined relative intensities were able to accurately distinguish samples from the two popubased on our previous analyses of histologic progression (Figure  4) , we would expect the vast majority (Ͼ80%) of the ducts to lations (Table 2) . When tested on a separate blinded set of 34 PanIN samples and 60 controls, the model was able to distincontain PanIN lesions. We performed terminal bleeds on a cohort (n ϭ 12) of PDX-1-Cre;LSL-KRAS G12D and P48
ϩ/Cre
;LSLguish cases and controls in this relatively young cohort of mice with a sensitivity of 90% (95% CI of 82.5%-99.9%) and a speci-KRAS G12D animals and prepared multiple serum samples from each animal (Table 1) . Each animal had extensive, histologically ficity of 87% (95% CI of 81.6%-99.9%). In addition, we note ;LSLpitulates some important genetic features of human pancreatic cancer; however, this progression does not occur through histo-KRAS G12D mice were detected with equal fidelity, suggesting that the identified proteomic signature was most likely related logically defined PanIN lesions, and the relationship of this model to human pancreatic carcinogenesis remains unclear to the presence of PanIN and not to the minor extrapancreatic pathology in these animals, which differs between the two co- (Wagner et al., 2001) . We have demonstrated here that targeted endogenous expression of an oncogenic KRAS allele in the horts. Thus, these results demonstrate that it is possible to detect even very early preinvasive disease in the serum promouse pancreas initiates the development of PanINs identical to all three stages found in the cognate human condition. At teome.
low frequency, mice with PanIN spontaneously develop both locally invasive adenocarcinoma and metastatic disease, with Discussion sites of spread exactly as found in human pancreatic cancer, underscoring both the relevance of this model and establishing The generation of an animal model that incorporates the genetic PanINs as bona fide precursors to pancreatic ductal adenocarcievents and faithfully recapitulates the cardinal features of invanoma. sive pancreatic ductal adenocarcinoma, or of the precursor leTransgenic animal models differ from those targeting endogsions collectively termed pancreatic intraepithelial neoplasias enous gene expression in several important ways. First, the (PanINs), has remained elusive to date. Targeted disruption of random nature of transgene insertion into the host genome a number of tumor suppressor genes believed to be important results in unpredictable positional effects on levels of expresin human pancreatic oncogenesis, including p53 (Donehower sion. Second, in constructs driven by heterologous promoters, et al., 1992; Jacks et al., 1994), p16 INK4a (Serrano et al., 1996) , the normal physiological regulation of gene expression gov-DPC4 (Sirard et al., 1998), and BRCA2 (Suzuki et al., 1997) , has erned by the endogenous promoter is lost. The cellular effects not yielded any form of pancreatic pathology. The development of oncogenic RAS have been shown to be exquisitely dependent of oncogenic mutations thought to act as initiating events may upon both the levels and context of RAS expression in a number therefore represent the rate-limiting step. Two interesting and of experimental systems (reviewed in Shields et al., 2000) . In a distinct transgenic mouse models, each expressing a KRAS variety of cell types, ectopic overexpression of RAS induces oncogene from a different heterologous pancreatic-specific procell cycle arrest and senescence in the absence of cooperating moter, were recently described (Brembeck et al., 2003; Grippo tumor suppressor or oncogenic mutations (Land et al., 1983; . Although these mice did exhibit varying degrees Ruley, 1983; Serrano et al., 1997) . Conversely, endogenous and types of pancreatic pathology, they too failed to recapitulate expression of KRAS G12D in mouse embryo fibroblasts (MEFs) the signature features of PDA or of PanIN. We, too, have prestimulates proliferation and induces focus formation in culture viously engineered a mouse to overexpress KRAS G12D from the without evidence of additional karyotypic events (D.A.T. et al., acinar cell-specific MIST-1 promoter. These mice exhibit widesubmitted). Moreover, targeted expression of this allele in the spread acinar metaplasia and develop a mixed exocrine pancremouse lung causes hyperproliferative lesions that progress from atic cancer with cystic, acinar, and ductal features (D.A.T., N.
adenomas to adenocarcinomas (Jackson et al., 2001 ). These Willis, C. Pin, S. Konieczny, J. Glickman, and T.J., unpublished findings are consistent with the presumptive role of activating data). Finally, transgenic overexpression of TGF␣ in acinar cells RAS mutations as initiating events in a number of malignancies. also results in acinar-to-ductal metaplasia (Sandgren et al., During the preparation of this manuscript, the description 1990; Wagner et al., 1998) . When placed in a p53-deficient background, these mice develop an invasive disease that recaof a model involving conditional endogenous expression of an-other oncogenic KRAS allele (KRAS G12V ) was reported. This of Cre behind the P48 promoter means that, in principle, every cell of the adult pancreas in compound mutant mice has potenmodel employed a bicistronic allele (KRAS
G12V-IRES-␤-geo
) created by targeting a fused IRES-␤-geo cassette to the 3Ј untranslated tially rearranged the oncogenic KRAS allele to permit expression. Nevertheless, we see the slowly progressive acquisition region of a mutated KRAS locus (Guerra et al., 2003) . Interestingly, when bred with transgenic CMV-Cre animals, expression of ductal lesions similar to that seen in the transgenic, and hence stochastic, PDX-1-Cre-associated model. It may be that acinarof activated KRAS from this modified allele failed to induce pancreatic lesions or gastric epithelial hyperplasias in mice even to-ductal transdifferentiation is a relatively slow process that requires weeks to months in vivo after the activation of oncoup to 8 months of age, despite demonstrated translation of the bicistronic transcript by X-gal staining. Low-grade pancreatic genic KRAS expression. However, at least in explants of developing pancreatic buds transfected in vitro with Notch, the oblesions, described by the authors as ductal metaplasia, were seen only in the context of an additional mutation in a cyclinserved transdifferentiation of acinar-like cells occurred within 3-4 days (Miyamoto et al., 2003) . dependent kinase, CDK4 R24C (Cdk4 R24C has a markedly decreased binding affinity for p16
INK4a and thereby resists its tumor We favor an alternate scheme for the development of PanINs seen here. Pancreatic stem cells periodically undergo either cell suppressor affects). On the other hand, the transgenic ectopic expression of KRAS G12V from an epithelial-specific CK-19 prodivision to replenish themselves or enter into a differentiation pathway to replace an end-stage cell. We propose that the moter induces the formation of gastric mucous neck cell hyperplasias, and some pancreatic ductal hyperplasias, but fails to periodic diversion of a progenitor cell that expresses the rearranged KRAS G12D allele toward differentiation along a ductal recapitulate the true spectrum of PanINs (Brembeck et al., 2003) . Together with the findings reported here, these studies confirm pathway provides the basis for the evolution of a PanIN. Differentiation along acinar or islet cell pathways does not provide that both the levels of RAS expression and the cellular context conspire to determine biological outcome. It may be that the the proper context for KRAS G12D to induce true PanINs. Cellular injury, such as that which accompanies ductal obstruction and biological consequences of KRAS G12V and KRAS G12D oncogenes are distinct or, alternatively, that strain-specific effects are reassociated acute and chronic pancreatitis, stimulates increased entry of progenitor cells into the differentiation pathway and sponsible for some of the differences discussed here. However, it is also possible that the unusual configuration of the bicistronic increased numbers of PanINs, which in turn cause further obstruction and injury. This scenario is consistent with the inallele affects the expression and/or terminal splicing of the KRAS transcript, thereby decreasing the overall levels of oncogenic creased associated risk of developing pancreatic cancer in patients with chronic pancreatitis (Lowenfels et al., 1993) . Exper-RAS, or changing the relative ratio of the alternatively spliced KRAS-4A and KRAS-4B transcripts. Indeed, it has been shown iments are currently underway to formally address whether mature or progenitor cell compartments of the pancreas give rise that introduction into the mouse genome of a bicistronic construct, directing expression from a single promoter of genes to PanINs by breeding LSL-KRAS G12D mice to mice that express Cre recombinase from the Elastase or Cytokeratin-19 promotseparated by an IRES, results in markedly decreased expression levels of both transcripts compared with separate constructs ers, active in mature acinar and ductal cells, respectively. The findings of activated Notch signaling, as manifested by driven by independent promoters (Jankowsky et al., 2001 ).
In our system, excision of the silencing cassette upstream Hes1 expression, and increased expression of COX-2 and MMP-7 in PanINs each provide a basis for therapeutic and/or of an introduced KRAS G12D mutation can occur in pancreatic progenitor cells early in development, and in the islet cells (for chemoprevention strategies. Agents that interfere with each of these activities are already in approved or investigational use PDX-1-Cre crosses) or acinar cells (for P48-Cre crosses) of the adult mouse. Thus, the model accounts for the possibility that in the clinic. For example, inhibitors of ␥-secretase, one of the required proteases in transducing Notch receptor signaling, are the initiation of tumorigenesis occurs in tissue stem cell compartments while not precluding the study of such events in currently in clinical trials for Alzheimer's disease (Josien, 2002) . The use of nonsteroidal anti-inflammatory drugs has been assodifferentiated cells (Reya et al., 2001 ). As noted above, an alternate theory of the genesis of ductal adenocarcinoma in the ciated with a decreased incidence in pancreatic cancer (Anderson et al., 2002) , which together with the increased expression pancreas involves the metaplastic transdifferentiation of acinar to ductal cells. The robust expression of Hes1 and low, but of Cox-2 observed here in ductal lesions suggests that Cox-2 activity may represent an important part of the program of events detectable, levels of PDX-1 expression in the PanINs described here are consistent with the notion of a relatively undifferentiated initiated by oncogenic KRAS. Finally, matrix metalloproteinases have traditionally been thought to be important for late stages or inappropriately differentiated population of cells; of course, such cells could result from progenitor cells gone awry, or from of tumorigenesis involving invasion and metastasis and, accordingly, MMP inhibitors have been used in a number of trials the dedifferentiation of mature ductal or acinar cells. While we cannot formally exclude the possibility that transdifferentiation encompassing a variety of metastatic malignancies (Coussens et al., 2002) . Unfortunately, these trials were largely unsuccessof acinar to ductal cells occurs in our model system, several points would at least seem to argue against it being the preferred ful. Given the expression of MMP-7 in early-stage PanINs, it may be that these agents would be more efficacious in earlier route to PanINs. First, the overall PanIN burden and progression, cellular histology, activated signaling pathways, and serum prostages of disease or as chemopreventive agents. There are currently no non-invasive tests with sufficient senteomic signatures found in PDX-1-Cre;LSL-KRAS G12D and P48 ϩ/Cre ;LSL-KRAS G12D compound mutant mice are highly consitivity and specificity to detect pancreatic cancer early enough to effect cures (Hingorani and Tuveson, 2003; Rosty and Goggruous despite different modes of transmission of the Cre allele and consequent expression in adult pancreatic cells. Thus, we gins, 2002) . The most commonly used biomarker of invasive pancreatic cancer, CA (carbohydrate antigen) 19-9, is useful see essentially normal acinar and islet compartments, respectively, in each of these model systems. In addition, the knockin only for following disease progression or response to therapy (Yeo et al., 2002b) . Indeed, in a recent prospective study of man PanIN in the mouse that faithfully recapitulates the cardinal features of this precursor state to invasive pancreatic cancer. patients with clinically suspected pancreatic malignancy but without a radiographically evident mass, the sensitivity and
The presence of PanINs can be detected accurately in the serum proteome of mutant mice. The fidelity of the model is affirmed by specificity of CA 19-9 to detect the invasive cancer were only 67% and 88%, respectively (Urgell et al., 2000) . The very notion the spontaneous development of fully invasive and metastatic ductal adenocarcinomas. Thus, the model provides a unique of early detection requires reassessment for pancreatic cancer, however, as even resection of stage I invasive disease affords platform to study mechanisms of disease pathogenesis, to develop detection and therapeutic strategies for preinvasive disnegligible 10-year survival (Allison et al., 1998) . In the absence of therapies that kill metastatic pancreatic cancer cells, which ease in high-risk patient populations, and to systematically evaluate multigenic models of invasive and metastatic pancreatic apparently arise from the inception of malignant transformation, the only hope for cures lies in the detection and eradication of cancer. the preinvasive state. It is, of course, currently impossible to Experimental procedures develop a serologic test for PanIN in patients because of the conundrum of being unable to distinguish those that harbor the
Mouse strains
lesions from those who do not. The risks and difficulties of
The conditional LSL-KRAS G12D mice (Jackson et al., 2001) and P48 ϩ/Cre mice pancreatic needle biopsy preclude its routine use to establish (Kawaguchi et al., 2002) to routinely sample pancreatic tissue has also hampered the elaboration of histologic and genetic progression models for
Statistical analyses
Statistical analyses were carried out using Splus version 6.0 and Stata 8.0.
human PDA. Thus, it has not been possible to directly chronicle See the Supplemental Data for details.
the evolution of ductal pancreatic cancer with serial biopsies, as has been done with colorectal cancer, for example (Fearon
Serum proteomics
and Vogelstein, 1990) . A large body of evidence, accumulated Serum preparation, mass spectroscopy, and pattern recognition data analyover several decades from resected and autopsy specimens, ses were performed as previously described (Petricoin et al., 2002b) . Further has led to a very useful conceptual model of preinvasive disease details are supplied in the Supplemental Data.
involving progression through discrete stages. Though compel-
